Immune regulatory adjuvant approach to mitigate subcutaneous immunogenicity of monoclonal antibodies
IntroductionImmunogenicity continues to be a challenge for development and clinical utility of monoclonal antibodies, and there are gaps in our current ability to prevent anti-drug antibody development in a safe and antigen-specific manner.MethodsTo mitigate immunogenicity of monoclonal antibodies a...
Saved in:
| Main Authors: | Nicole L. Jarvi, Manali Patel, Krithika A. Shetty, Nhan H. Nguyen, Brooke F. Grasperge, Donald E. Mager, Robert M. Straubinger, Sathy V. Balu-Iyer |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2024-12-01
|
| Series: | Frontiers in Immunology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2024.1496169/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Scapular swelling: “subcutaneous cysticercosis unveiled”—a case report
by: Barundeep Singh, et al.
Published: (2024-12-01) -
Subcutaneous drug administration in palliative care
by: Carmen Matoses Chirivella, et al.
Published: (2015-01-01) -
Reactogenicity and Immunogenicity Against MPXV of the Intradermal Administration of Modified Vaccinia Ankara Compared to the Standard Subcutaneous Route
by: Valentina Mazzotta, et al.
Published: (2024-12-01) -
Generalized subcutaneous emphysema (pnenmoderma) in a dog
by: İlker Çamkerten, et al. -
Predicting the clinical subcutaneous absorption rate constant of monoclonal antibodies using only the primary sequence: a machine learning approach
by: Ronghua Bei, et al.
Published: (2024-12-01)